Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2006-06-05 | James Page, MD, 77, Prior to retiring in 1991 as a Vice President with Adria Laboratories, Inc. (2) Member of the Compensation Committee. (5) Member of the Administration Committee for the 1996 Employee Stock Option Plan and the Outside Director and Advisor Stock Option Plan. The Compensation Committee consists of Stephen Chen and James Page. |
| 2007-05-08 | James Page, MD (2)(3), 79 Prior to retiring in 1991 as a Vice President with Adria Laboratories, Inc., held various upper management level positions with Carter Wallace, Inc., Merck Sharpe & Dohme Research Laboratories and Wyeth Laboratories. (2) Member of the Compensation and Stock Option Committee. (3) Member of the Audit Committee. The Audit Committee consists of Stephen Chen, James Page, and Thomas Ulie. The Compensation and Stock Option Committee consists of Stephen Chen, James Page, and Thomas D’Alonzo. DIRECTORS’ FEES AND COMPENSATION DURING 2006 James Page, MD Cash Compensation Meeting Fees $2,000. |
Data sourced from SEC filings. Last updated: 2026-03-05